SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 2 filers reported holding SYNDAX PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,332 | +2.4% | 11,111 | +47.6% | 0.01% | 0.0% |
| Q2 2023 | $157,603 | +235128.4% | 7,530 | +138.6% | 0.01% | +150.0% |
| Q1 2023 | $67 | -46.8% | 3,156 | -36.2% | 0.00% | -60.0% |
| Q4 2022 | $126 | -99.9% | 4,947 | -31.6% | 0.01% | +66.7% |
| Q3 2022 | $174,000 | +56.8% | 7,235 | +25.9% | 0.00% | +50.0% |
| Q2 2022 | $111,000 | +177.5% | 5,745 | +148.6% | 0.00% | – |
| Q1 2022 | $40,000 | -74.2% | 2,311 | -67.4% | 0.00% | -100.0% |
| Q4 2021 | $155,000 | +64.9% | 7,093 | +44.7% | 0.00% | +50.0% |
| Q3 2021 | $94,000 | -6.0% | 4,901 | -15.6% | 0.00% | -33.3% |
| Q2 2021 | $100,000 | +233.3% | 5,808 | +333.1% | 0.00% | +200.0% |
| Q1 2021 | $30,000 | +25.0% | 1,341 | +22.5% | 0.00% | 0.0% |
| Q4 2020 | $24,000 | -90.5% | 1,095 | -93.6% | 0.00% | -66.7% |
| Q3 2020 | $252,000 | +327.1% | 17,044 | +328.2% | 0.00% | +50.0% |
| Q2 2020 | $59,000 | +883.3% | 3,980 | +432.1% | 0.00% | – |
| Q3 2019 | $6,000 | -33.3% | 748 | -23.4% | 0.00% | -100.0% |
| Q2 2019 | $9,000 | -69.0% | 977 | -82.1% | 0.00% | -50.0% |
| Q1 2019 | $29,000 | +45.0% | 5,463 | +21.0% | 0.00% | +100.0% |
| Q4 2018 | $20,000 | +53.8% | 4,515 | +150.3% | 0.00% | 0.0% |
| Q2 2018 | $13,000 | -62.9% | 1,804 | -39.1% | 0.00% | -66.7% |
| Q3 2017 | $35,000 | +34.6% | 2,961 | -16.5% | 0.00% | 0.0% |
| Q4 2016 | $26,000 | +1200.0% | 3,547 | +1302.0% | 0.00% | – |
| Q2 2016 | $2,000 | -81.8% | 253 | -70.7% | 0.00% | -100.0% |
| Q1 2016 | $11,000 | – | 863 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |